Premium Research
One biotech IPO cleared both of our models. Here is your buy instruction, with a price limit.
By Sean Levine On November 9, 202603:08 PM Eastern
Q3 revenue jumped, costs jumped more, and we ran the numbers through our model. Here’s what came out.
By Al Qureiyeh On November 9, 202603:05 PM Eastern
Bank this two-week gain before tomorrow’s inflation report.
By Michael A. Robinson On November 9, 202610:00 AM Eastern
The selloff triggered our buy order on a top biotech. Here’s what we added, what we sold and the stop to put in.
By Michael A. Robinson On November 9, 202608:59 AM Eastern
AI stocks sold off hard after the election. Here’s what we closed, and what we’re watching to get back in.
By Chris Graebe On November 6, 202602:50 PM Eastern
If you invested, here’s what happens next, and the one email you don’t want to miss.
Weiss Ultimate Portfolio
Subscription
By Gavin Magor On November 6, 202601:10 PM Eastern
Seven of our top-rated holdings rose while the S&P 500 fell 3%. Here’s why we’re holding steady.
Wealth Megatrends
Subscription
By Sean Brodrick On November 6, 202612:30 PM Eastern
Plus, here’s where you sit with all post-earnings positions.
By Michael A. Robinson On November 6, 202611:06 AM Eastern
Here’s why I’m bullish for the long term.
By Nilus Mattive On November 6, 202610:56 AM Eastern
Plus, two positions reported glowing earnings and are turning around in a big way.